Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001267602-15-000051
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-01 16:05:36
Reporting Period:
2015-08-24
Filing Date:
2015-09-01
Accepted Time:
2015-09-01 16:05:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1489535 W. Calvin Roberts 6120 Windward Parkway
Suite 290
Alpharetta GA 30005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-24 6,389 $3.00 6,389 No 4 P Direct
Common Stock Acquisiton 2015-08-24 2,150 $3.00 2,150 No 4 P Indirect See Footnote (2)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect See Footnote (2)
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 95,620 Indirect See Footnote (3)
Common Stock 95,820 Indirect See Footnote (4)
Common Stock 95,621 Indirect See Footnote (5)
Footnotes
  1. These shares were acquired by the Calvin W. Roberts IRA.
  2. These shares were acquired and are held by the Andrea C. Roberts IRA. Calvin Roberts disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
  3. The shares are held by The David Roberts Trust. Calvin Roberts is a Trustee of The David Roberts Trust. Calvin Roberts disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
  4. The shares are held by The Lindsay Roberts Trust. Calvin Roberts is a Trustee of The Lindsay Roberts Trust. Calvin Roberts disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
  5. The shares are held by The Joanna Roberts Trust. Calvin Roberts is a Trustee of The Joanna Roberts Trust. Calvin Roberts disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for the purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.